Related Experiment Video

Updated: Nov 21, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.3K

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment

Raul Vintimilla1, Kishore Balasubramanian2, James Hall1

  • 1Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, Texas, USA.

Dementia and Geriatric Cognitive Disorders Extra
|January 14, 2021
PubMed
Abstract

Insights

Cardiovascular risk factors significantly impact cognitive function in Mexican Americans with mild cognitive impairment (MCI). Comorbid conditions, like diabetes and obesity, worsen cognitive deficits, increasing dementia risk.

Area of Science:

  • Neuroscience
  • Gerontology
  • Public Health

Background:

  • Cardiovascular risk factors are increasingly recognized as contributors to cognitive decline.
  • Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia.
  • Understanding these links is crucial for early intervention strategies.

Purpose of the Study:

  • To investigate the association between hypertension, diabetes, dyslipidemia, and obesity with cognitive functioning in Mexican Americans with MCI.
  • To determine if the presence of multiple risk factors exacerbates cognitive impairment.

Main Methods:

  • A cohort of 100 Mexican Americans (ages 50-86) diagnosed with MCI was studied.
  • Cardiovascular risk factors were assessed via self-report and standardized measures.
  • Cognitive function was evaluated using a battery of neuropsychological tests, including MMSE and memory/executive function assessments.
  • Statistical analyses included independent samples t tests and two-way ANOVAs, controlling for covariates.

Main Results:

  • Obesity was associated with differences in memory scores.
  • The combination of hypertension and diabetes correlated with poorer language abilities.
  • Diabetes and dyslipidemia were linked to impaired executive function.
  • Diabetes combined with obesity showed associations with deficits in memory and language.

Conclusions:

  • Cardiovascular risk factors are significantly associated with cognitive dysfunction in individuals with MCI.
  • The presence of comorbid cardiovascular risk factors amplifies cognitive deficits across multiple domains.
  • These findings suggest that managing cardiovascular health may be vital in mitigating dementia risk in at-risk populations.
Keywords:
Cardiovascular risk factorsMexican AmericanMild cognitive impairment

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.0K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
672
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
296
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
521
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
332
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
183
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K